Metabolically Armed EGFRvIII CAR-T cells therapy (Leman Biotech)

N/A

Report date: 2025/11/26 20:00:44

Base Information

Drug NameMetabolically Armed EGFRvIII CAR-T cells therapy (Leman Biotech)
Drug Alias NameMeta10-EGFRvIIILMC005
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionEpidermal growth factor receptor variant III modulators
TargetsEpidermal growth factor receptor variant III
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLeman Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLeman Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A